BCL2L13 Antikörper (Middle Region)

Produktnummer ABIN926875

Dieser Kaninchen Polyklonal Antikörper detektiert spezifisch BCL2L13 in WB. Es zeigt Reaktivität gegenüber Proben von Human.

Kurzübersicht für BCL2L13 Antikörper (Middle Region) (ABIN926875)

Target: BCL2L13 (BCL2-Like 13 (Apoptosis Facilitator) (BCL2L13))

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser BCL2L13 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB)

Produktdetails anti-BCL2L13 Antikörper

Bindungsspezifität: Middle Region

Aufreinigung: Purified

Immunogen: BCL2 L13 antibody was raised in rabbit using the middle region of BCL2 13 as the immunogen

Anwendungsinformationen

Applikationshinweise: WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator.

Kommentare:

BCL2L13 Blocking Peptide, , is also available for use as a blocking control in assays to test for specificity of this BCL2L13 antibody

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Konzentration: Lot specific

Buffer: Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.

Handhabung: Avoid repeated freeze/thaw cycles.

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung: Store at 4 °C, following reconstitution, aliquot and store at -20 °C.

Details zu BCL2L13

Target: BCL2L13 (BCL2-Like 13 (Apoptosis Facilitator) (BCL2L13))

Andere Bezeichnung: BCL2L13

Hintergrund: BCL2L13 May promote the activation of caspase-3 and apoptosis. Synonyms: Polyclonal BCL2L13 antibody, Anti-BCL2L13 antibody, BCL2-like 13, apoptosis facilitator antibody, BCL-RAMBO antibody, MIL1 antibody.

Pathways: Positive Regulation of Endopeptidase Activity